Estrogen and estrogen–progestin replacement therapy and risk of postmenopausal breast cancer in Canada

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.13, Iss.6, 2002-08, pp. : 583-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen–progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

By Porch J.V.

Cancer Causes and Control, Vol. 13, Iss. 9, 2002-11 ,pp. : 847-854

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Replacement Therapy and Risk of Epithelial Ovarian Cancer

By Risch H.A.

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 254-257

Academic Press

Access to resources Recommend Favorite

Estrogen therapy and breast cancer

Future Oncology, Vol. 2, Iss. 3, 2006-06 ,pp. : 329-331

Future Medicine

Access to resources Recommend Favorite

Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)

By Newcomb P.A.

Cancer Causes and Control, Vol. 14, Iss. 2, 2003-03 ,pp. : 195-201

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Replacement Therapy in Women with Prior Diagnosis and Treatment for Breast Cancer

By Vassilopoulou-Sellin R. Theriault R. Klein M.J.

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 89-93

Elsevier

Access to resources Recommend Favorite